Literature DB >> 7835939

Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice.

A G Baxter1, A C Horsfall, D Healey, P Ozegbe, S Day, D G Williams, A Cooke.   

Abstract

Non-obese diabetic (NOD) mice spontaneously develop organ-specific autoimmunity and are widely used as a model for diabetes. Aged NOD mice also exhibit some features of non-organ-specific autoimmune rheumatic disease such as anti-nuclear antibodies and late-onset haemolytic anaemia. Here, we report that a single dose of 2.6 x 10(7) heat-killed bacillus Calmette-Guérin (BCG) i.v. in 8-week-old NOD mice prevented diabetes but precipitated a syndrome similar to systemic lupus erythematosus (SLE). Treated mice developed haemolytic anaemia, anti-DNA and anti-Sm anti-nuclear autoantibodies and an increased severity of sialadenitis. Perivascular lymphocytic infiltration in the kidneys and glomerular immune complex deposition were also found. The action of BCG appeared to be mediated by an adjuvant-like activity as treated mice showed a substantial increase in reticuloendothelial cell function and enhanced antigen presentation capacity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7835939      PMCID: PMC1414944     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination.

Authors:  M Harada; Y Kishimoto; S Makino
Journal:  Diabetes Res Clin Pract       Date:  1990-01       Impact factor: 5.602

2.  The nonobese diabetic mouse model. Independent expression of humoral and cell-mediated autoimmune features.

Authors:  A Lehuen; A Bendelac; J F Bach; C Carnaud
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

3.  The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex.

Authors:  M Hattori; J B Buse; R A Jackson; L Glimcher; M E Dorf; M Minami; S Makino; K Moriwaki; H Kuzuya; H Imura
Journal:  Science       Date:  1986-02-14       Impact factor: 47.728

4.  Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.

Authors:  M W Sadelain; H Y Qin; J Lauzon; B Singh
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

5.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

6.  Regulation of resistance to leprosy by chromosome 1 locus in the mouse.

Authors:  E Skamene; P Gros; A Forget; P J Patel; M N Nesbitt
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

7.  Specificity of anti-Sm antibodies by ELISA for systemic lupus erythematosus: increased sensitivity of detection using purified peptide antigens.

Authors:  M Field; D G Williams; P Charles; R N Maini
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

8.  Characterization of antinuclear autoantibodies present in the serum from nonobese diabetic (NOD) mice.

Authors:  M G Humphreys-Beher; L Brinkley; K R Purushotham; P L Wang; Y Nakagawa; D Dusek; M Kerr; N Chegini; E K Chan
Journal:  Clin Immunol Immunopathol       Date:  1993-09

9.  Immunogenetics of BCG-induced anergy in mice. Control by Igh- and H-2-linked genes.

Authors:  A H Callis; D J Schrier; C S David; V L Moore
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

10.  Comparison of high- and low-diabetes-incidence NOD mouse strains.

Authors:  A G Baxter; M A Adams; T E Mandel
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

View more
  24 in total

Review 1.  Polyspecificity of autoimmune responses in type 1 (autoimmune) diabetes.

Authors:  L M Esteban; A G Baxter
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 2.  Immunisation and type 1 diabetes mellitus: is there a link?

Authors:  M Hiltunen; M Lönnrot; H Hyöty
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

Review 3.  Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes?

Authors:  Anne Cooke
Journal:  Immunology       Date:  2009-01       Impact factor: 7.397

4.  Mechanisms of Mycobacterium avium-induced resistance against insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice: role of Fas and Th1 cells.

Authors:  T C Martins; A P Aguas
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

5.  Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region.

Authors:  Junichiro Irie; Yuehong Wu; David A Sass; William M Ridgway
Journal:  Immunogenetics       Date:  2006-01-27       Impact factor: 2.846

Review 6.  Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders.

Authors:  G A W Rook; V Adams; J Hunt; R Palmer; R Martinelli; L Rosa Brunet
Journal:  Springer Semin Immunopathol       Date:  2003-10-08

7.  New insights into disease-specific absence of complement factor H related protein C in mouse models of spontaneous autoimmune diseases.

Authors:  Gaurav Mehta; Viviana P Ferreira; Christine Skerka; Peter F Zipfel; Nirmal K Banda
Journal:  Mol Immunol       Date:  2014-07-15       Impact factor: 4.407

8.  Mycobacteria, an environmental enhancer of lupus nephritis in a mouse model of systemic lupus erythematosus.

Authors:  Christine G Hawke; Dorothy M Painter; Paul D Kirwan; Rosemary R Van Driel; Alan G Baxter
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

9.  Characterization and specificity of B-cell responses in lupus induced by Mycobacterium bovis in NOD/Lt mice.

Authors:  A C Horsfall; R Howson; P Silveira; D G Williams; A G Baxter
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

10.  Allelic variation of Ets1 does not contribute to NK and NKT cell deficiencies in type 1 diabetes susceptible NOD mice.

Authors:  Margaret A Jordan; Lynn D Poulton; Julie M Fletcher; Alan G Baxter
Journal:  Rev Diabet Stud       Date:  2009-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.